Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial
Merck and Moderna's mRNA cancer vaccine hit its Phase 3 trial endpoint, showing improved recurrence-free survival in melanoma patients after surgery.
Fox News
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Fox News.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Fox News (www.foxnews.com), a Tier B publisher, filed this report on . CurrentWire published this page 23 hours later, on .
Signal breakdown
CurrentWire ranked this story 34.1 of 100 in the snapshot this page was rendered from.
- Freshness
- 4.6 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: story prominence, 8 of 10. How each signal is calculated.
Filed under Health · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.